Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with NPM1-Mutated Acute Myeloid Leukemia
Hartmut Doehner,Daniela Weber,Julia Krzykalla,Walter Fiedler,Michael W. M. Kuehn,Thomas Schroeder,Karin Mayer,Michael Luebbert,Mohammad Wattad,Katharina Goetze,Lars Fransecky,Elisabeth Koller,Gerald Wulf,Jan Schleicher,Mark Ringhoffer,Richard Greil,Bernd Hertenstein,Juergen Krauter,Uwe M. Martens,David Nachbaur, Maisun Abu Samra, Sigrid Machherndl-Spandl, Nadezda Basara, Claudia Leis, Anika Schrade, Silke Kapp-Schwoerer, Lars Bullinger, Felicitas R. Thol, Michael Heuser, Peter Paschka, Verena Gaidzik, Maral Saadati, Axel Benner, Richard F. Schlenk, Konstanze Doehner, Arnold Ganser Blood（2022）
Key words
acute myeloid leukemia,intensive chemotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper